Events

Lecture Title: “Expanding the Collaborative Care Model in Oncology” William Pirl, MD, MPH Chair, Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center Member, Memorial Sloan Kettering Cancer Center; Attending, Memorial Hospital Member of the Faculty, WCMC

SAFE Webinar Event Part of the SAFE Program (Support, Advocacy, Family Education) Join our free community education event on inhalant use and addiction led by Dr. John Mahlstedt, a board-certified child, adolescent, and addiction psychiatrist. Learn more about this often-overlooked form of substance use and its impact on youth health and well-being. What you'll learn: What inhalants are and why young people may use themThe risks and health effects of inhalant useCommon symptoms and signs of use Speaker: John Mahlstedt, M.D. - Assistant Professor of Clinical Psychiatry at Weill Cornell Medicine and Assistant Attending Psychiatrist at NewYork-Presbyterian Hospital

2026 Clinician Education Series hosted by The Center for Youth Mental Health at NewYork-Presbyterian Co-sponsored by the Weill Cornell Medicine Academy for Behavioral Health and Continuing Education Free registration: https://www.eeds.com/portal_live_events.aspx?ConferenceID=105467 Please note that registration will close at 11:59pm ET on the day before the event (October 22). 1 CE Credit Hour Available FREE for Psychologists (NY & APA-accepted), Social Workers (NY) and Mental Health Counselors (NY) Learn more CE information: https://acrobat.adobe.com/id/urn:aaid:sc:us:8a1633e4-408d-49de-94c6-8832... Event Abstract: Cannabis remains the most widely used federally prohibited substance among U.S. adolescents, and the clinical landscape has changed faster than the evidence base guiding our response to it. This presentation opens with national surveillance data, distinguishing prevalence from exposure and explaining why rising potency and the shift toward new methods of cannabis consumption (concentrates and edibles) require further study. It then reviews short- and long-term associations, including acute cognitive and psychomotor impairment, hyperemesis, and psychotic symptoms, alongside longitudinal risk for cannabis use disorder, psychosis onset, mood and suicidality outcomes, and educational attainment. The presentation will then shift to review current assessment and treatment options for cannabis use in young people. Adolescence and young adulthood is a critical time to intervene, as over 90% of people with substance use disorders begin their substance use during adolescence. Unfortunately, the vast majority of adolescents and young adults with substance use disorders go untreated, and they are the least likely age group to receive treatment. The American Academy of Child and Adolescent Psychiatry (AACAP) recently published revised principles for the treatment of adolescent substance use disorders. These include the need for clinicians to intervene as young as possible, to tailor treatment to the individual’s needs, using evidence-based practices including motivational interviewing, cognitive behavioral therapy, behavioral interventions, family interventions, among other items. This presentation will review the rationale for evidence-based treatments, as well as a multicomponent toolkit aimed at helping clinicians use evidenced-based modalities to treat youth and young adults with cannabis misuse. Learning Objectives: 1. Describe national epidemiological trends in cannabis use among youth. 2. Discuss the short- and long-term associations between cannabis use and health and behavioral outcomes in youth. 3. Explain neurobiological changes associated with cannabis use during youth and adolescence. 4. Describe treatment modalities for treating substance use disorders in adolescents and young adults. 5. Compare different approaches for treating substance use disorders and problematic substance use in adolescents and young adults. Featured Presenters: Ryan S. Sultan, M.D. - Assistant Professor of Clinical Psychiatry, Columbia University Vagelos College of Physicians and Surgeons John Mahlstedt, M.D. - Assistant Professor of Clinical Psychiatry, Weill Cornell Medicine

“The Missing Children: Conversion Therapy, the First Amendment, and Chiles v. Salazar” Anne Dailey, J.D., University of Connecticut School of Law

Lecture Title: "Where Are We? Where Have We Been? Anxiety, Depression and Trauma" John T. Walkup, MD Chair, Pritzker Department of Psychiatry and Behavioral Health Ann and Robert H. Lurie Children's Hospital of Chicago Margaret C. Osterman Professor of Psychiatry Northwestern University Feinberg School of Medicine

Lecture Title: “Deprescribing Psychotropic Medications and the Identification of Pharmacological Endpoints” Joseph F. Goldberg, MD Clinical Professor of Psychiatry Icahn School of Medicine, Mount Sinai

“Repairing the Family: Psychoanalysis and Terror in Cold War Argentina” Marco Ramos, M.D., Ph.D., Yale University

Lecture Title: “Antidepressant Treatment in Pregnancy: Are We Asking the Right Questions?” Katherine L. Wisner, MD MS Professor of Psychiatry and Behavioral Sciences and Pediatrics Prenatal Mental Health, Developing Brain Institute Children’s National Hospital, Washington DC Professor of Obstetrics and Gynecology, George Washington University School of Medicine and Health Sciences

“LSD, Speed, and The Making of Biological Psychiatry” Justin Garson, Ph.D., Hunter College and The Graduate Center, CUNY

Lecture Title: “Probing and Rescuing Dysfunctional Brain Circuits in Depression” Conor Liston, MD, PhD Robert Michels, MD, Professor of Psychiatry Vice Chair for Precision Psychiatry Weill Cornell Medicine